Kosuke Kato

2.0k total citations
47 papers, 1.3k citations indexed

About

Kosuke Kato is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Kosuke Kato has authored 47 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 10 papers in Immunology. Recurrent topics in Kosuke Kato's work include Glycosylation and Glycoproteins Research (13 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers) and Immune Response and Inflammation (8 papers). Kosuke Kato is often cited by papers focused on Glycosylation and Glycoproteins Research (13 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers) and Immune Response and Inflammation (8 papers). Kosuke Kato collaborates with scholars based in United States, Japan and China. Kosuke Kato's co-authors include Erik P. Lillehoj, Wenju Lu, Kwang Chul Kim, K. Chul Kim, Hirofumi Kai, Louise Hecker, Takeshi Koga, Sandra Gendler, K. Ikeda and S. Aoyama and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Cancer Research.

In The Last Decade

Kosuke Kato

45 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kosuke Kato United States 21 564 327 321 153 137 47 1.3k
Yan Jiang China 18 581 1.0× 127 0.4× 163 0.5× 46 0.3× 83 0.6× 61 1.3k
Li Ou China 19 351 0.6× 74 0.2× 348 1.1× 278 1.8× 88 0.6× 69 1.4k
Claudia Champagne Canada 17 625 1.1× 48 0.1× 354 1.1× 121 0.8× 110 0.8× 20 1.0k
Lisa Tucker‐Kellogg Singapore 19 539 1.0× 46 0.1× 85 0.3× 80 0.5× 89 0.6× 59 1.3k
Violetta Borelli Italy 17 119 0.2× 145 0.4× 232 0.7× 92 0.6× 55 0.4× 56 776
Ayako Ohno Japan 21 1.0k 1.8× 67 0.2× 121 0.4× 27 0.2× 135 1.0× 45 1.6k
Yogesh K. Gupta United States 21 1.0k 1.9× 76 0.2× 87 0.3× 38 0.2× 68 0.5× 37 1.6k
David W. Keizer Australia 18 591 1.0× 34 0.1× 158 0.5× 41 0.3× 105 0.8× 41 1.1k
Hiroshi Yokota Japan 19 561 1.0× 48 0.1× 56 0.2× 76 0.5× 27 0.2× 61 1.1k
R. K. Singh India 15 484 0.9× 17 0.1× 212 0.7× 121 0.8× 141 1.0× 39 906

Countries citing papers authored by Kosuke Kato

Since Specialization
Citations

This map shows the geographic impact of Kosuke Kato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kosuke Kato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kosuke Kato more than expected).

Fields of papers citing papers by Kosuke Kato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kosuke Kato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kosuke Kato. The network helps show where Kosuke Kato may publish in the future.

Co-authorship network of co-authors of Kosuke Kato

This figure shows the co-authorship network connecting the top 25 collaborators of Kosuke Kato. A scholar is included among the top collaborators of Kosuke Kato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kosuke Kato. Kosuke Kato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kato, Kosuke, et al.. (2025). Psilocybin treatment extends cellular lifespan and improves survival of aged mice. PubMed. 11(1). 55–55. 1 indexed citations
3.
Kato, Kosuke, Naomi J. Logsdon, Mohamed Mohamed, et al.. (2020). Impaired Myofibroblast Dedifferentiation Contributes to Nonresolving Fibrosis in Aging. American Journal of Respiratory Cell and Molecular Biology. 62(5). 633–644. 60 indexed citations
4.
Kato, Kosuke & Louise Hecker. (2020). NADPH oxidases: Pathophysiology and therapeutic potential in age-associated pulmonary fibrosis. Redox Biology. 33. 101541–101541. 50 indexed citations
5.
Kato, Kosuke, et al.. (2020). Nampt Promotes Pro-Fibrotic Myofibroblasts Phenotypes in Age-Dependent Pulmonary Fibrosis. A7879–A7879. 1 indexed citations
6.
Kato, Kosuke, Yoshiki Mukudai, Chihiro Ito, et al.. (2017). Opposite effects of tumor protein D (TPD) 52 and TPD54 on oral squamous cell carcinoma cells. International Journal of Oncology. 50(5). 1634–1646. 10 indexed citations
7.
Kato, Kosuke, et al.. (2017). Muc1 deficiency exacerbates pulmonary fibrosis in a mouse model of silicosis. Biochemical and Biophysical Research Communications. 493(3). 1230–1235. 13 indexed citations
8.
Kato, Kosuke, Nicole Morgan, Kenneth S. Knox, et al.. (2017). Pseudomonas aeruginosa increases MUC1 expression in macrophages through the TLR4-p38 pathway. Biochemical and Biophysical Research Communications. 492(2). 231–235. 12 indexed citations
9.
Mukudai, Yoshiki, Meilin Zhang, Seiji Kondo, et al.. (2016). Methanol and Butanol Extracts of Paeonia lutea Leaves Repress Metastasis of Squamous Cell Carcinoma. Evidence-based Complementary and Alternative Medicine. 2016(1). 6087213–6087213. 4 indexed citations
10.
Kato, Kosuke, et al.. (2015). Membrane-Tethered MUC1 Mucin Counter-Regulates the Phagocytic Activity of Macrophages. American Journal of Respiratory Cell and Molecular Biology. 54(4). 515–523. 23 indexed citations
11.
Kato, Kosuke, Erik P. Lillehoj, & Kwang Chul Kim. (2015). Pseudomonas aeruginosa stimulates tyrosine phosphorylation of and TLR5 association with the MUC1 cytoplasmic tail through EGFR activation. Inflammation Research. 65(3). 225–233. 17 indexed citations
12.
Kato, Kosuke, Erik P. Lillehoj, & Kwang Chul Kim. (2014). MUC1 Regulates Epithelial Inflammation and Apoptosis by PolyI:C through Inhibition of Toll/IL-1 Receptor-Domain–Containing Adapter-Inducing IFN-β (TRIF) Recruitment to Toll-like Receptor 3. American Journal of Respiratory Cell and Molecular Biology. 51(3). 446–454. 28 indexed citations
13.
Xu, Xiuling, Alexandria Wells, Mabel T. Padilla, et al.. (2014). A signaling pathway consisting of miR-551b, catalase and MUC1 contributes to acquired apoptosis resistance and chemoresistance. Carcinogenesis. 35(11). 2457–2466. 56 indexed citations
14.
Lillehoj, Erik P., et al.. (2013). Cellular and Molecular Biology of Airway Mucins. International review of cell and molecular biology. 303. 139–202. 139 indexed citations
15.
Kato, Kosuke, et al.. (2012). Prevention of lung injury by Muc1 mucin in a mouse model of repetitive Pseudomonas aeruginosa infection. Inflammation Research. 61(9). 1013–1020. 28 indexed citations
16.
Kato, Kosuke, et al.. (2011). Antiinflammatory Role of MUC1 Mucin during Infection with Nontypeable Haemophilus influenzae. American Journal of Respiratory Cell and Molecular Biology. 46(2). 149–156. 60 indexed citations
17.
Ueno, Keiko, Takeshi Koga, Kosuke Kato, et al.. (2007). MUC1 Mucin Is a Negative Regulator of Toll-Like Receptor Signaling. American Journal of Respiratory Cell and Molecular Biology. 38(3). 263–268. 139 indexed citations
18.
Kato, Kosuke, Wenju Lu, Hirofumi Kai, & K. Chul Kim. (2007). Phosphoinositide 3-kinase is activated by MUC1 but not responsible for MUC1-induced suppression of Toll-like receptor 5 signaling. American Journal of Physiology-Lung Cellular and Molecular Physiology. 293(3). L686–L692. 33 indexed citations
19.
Lu, Wenju, Akinori Hisatsune, Takeshi Koga, et al.. (2006). Cutting Edge: Enhanced Pulmonary Clearance of Pseudomonas aeruginosa by Muc1 Knockout Mice. The Journal of Immunology. 176(7). 3890–3894. 116 indexed citations
20.
Shuto, Tsuyoshi, Kosuke Kato, Yoko Mori, et al.. (2005). Membrane-anchored CD14 is required for LPS-induced TLR4 endocytosis in TLR4/MD-2/CD14 overexpressing CHO cells. Biochemical and Biophysical Research Communications. 338(3). 1402–1409. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026